A Brief Evidence-Based Curriculum Can Improve Internal Medicine Residents’ Ability to Successfully Manage Irritable Bowel Syndrome and Reduce Unnecessary Diagnostic Testing

2014 ◽  
Vol 109 ◽  
pp. S540
Author(s):  
Amoah Yeboah-Korang ◽  
Shakthi Kumar ◽  
Seema Gandhi ◽  
Sharon Jedel ◽  
Michael Brown
Keyword(s):  
Internal Medicine ◽  
Irritable Bowel Syndrome ◽  
Diagnostic Testing ◽  
Evidence Based ◽  
Internal Medicine Residents ◽  
Irritable Bowel

scholarly journals Evidence-based clinical practice guidelines for irritable bowel syndrome

2014 ◽  
Vol 50 (1) ◽  
pp. 11-30 ◽  
Author(s):  
Shin Fukudo ◽  
Hiroshi Kaneko ◽  
Hirotada Akiho ◽  
Masahiko Inamori ◽  
Yuka Endo ◽  
...  
Keyword(s):  
Irritable Bowel Syndrome ◽  
Clinical Practice ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Evidence Based ◽  
Irritable Bowel

scholarly journals S510A Prevalence of Irritable Bowel Syndrome (IBS) in an Underserved Community Internal Medicine Practice in Charlotte, North Carolina

2021 ◽  
Vol 116 (1) ◽  
pp. S228-S229
Author(s):  
Darius Whitmore-Carter ◽  
Jessica Sang ◽  
Suneet Kaur ◽  
Elyse Thakur ◽  
Jason Baker ◽  
...  
Keyword(s):  
Internal Medicine ◽  
North Carolina ◽  
Irritable Bowel Syndrome ◽  
Underserved Community ◽  
Irritable Bowel

scholarly journals Neuromodulators in the Brain-Gut Axis: their Role in the Therapy of the Irritable Bowel Syndrome

2021 ◽  
Author(s):  
Mihaela Fadgyas Stanculete ◽  
Dan Lucian Dumitrascu ◽  
Douglas Drossman
Keyword(s):  
Quality Of Life ◽  
Irritable Bowel Syndrome ◽  
Evidence Based ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related ◽  
Irritable Bowel ◽  
The Brain ◽  
Rome Iv

Irritable bowel syndrome (IBS) is a clinically well-defined chronic condition that is now understood as a disorder of gut-brain regulation, as established in the work of the Rome IV committees coordinated by Drossman, 2016. People with IBS often report high disability levels and poor health-related quality of life. Drug therapy focuses on reducing main symptoms and disability and improving health-related quality of life. Central neuromodulators reduce IBS symptoms by targeting dysregulated pain and motility related to gut-brain dysregulation. It can also treat associated mental health symptoms. Based on their multiple effects on central and peripheral mechanisms, neuromodulators have been used to treat IBS patients. This review presents the rationale supporting medication treatments for specific IBS symptoms, discusses evidence-based management of IBS with central neuromodulators, and reviews the progress in the research for new neuromodulators.

Sign in / Sign up

Export Citation Format

Share Document